Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study)

Ulrich, S; Speich, R; Domenighetti, G; Geiser, T; Aubert, JD; Rochat, T; Huber, L; Treder, U; Fischler, M (2007). Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss medical weekly, -137(41-42), pp. 573-80. Muttenz: EMH Schweizerischer Ärzteverlag

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Geiser, Thomas

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:56

Last Modified:

04 May 2014 23:16

Web of Science ID:

000250308100002

URI:

https://boris.unibe.ch/id/eprint/23844 (FactScience: 44815)

Actions (login required)

Edit item Edit item
Provide Feedback